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For  more  than  50  years,  reactive  oxygen  species  have  been  considered  as  harmful  agents,  which  can  attack
proteins,  lipids  or nucleic  acids.  In  order to deal  with  reactive  oxygen  species,  there  is a sophisticated
system  developed  in  mitochondria  to prevent  possible  damage.  Indeed,  increased  reactive  oxygen  species
levels contribute  to pathomechanisms  in several  human  diseases,  either  by its impaired  defense  system




reactive  oxygen  species  in many  cellular  signaling  pathways  has  been  unraveled.  Homeostatic  levels were
shown to be  necessary  for  correct  differentiation  during  embryonic  expansion  of stem  cells.  Although
the  mechanism  is still not  fully  understood,  we cannot  only  regard  reactive  oxygen  species  as a  toxic
by-product  of mitochondrial  respiration  anymore.
This  article  is  part  of a  Directed  Issue  entitled:  Energy  Metabolism  Disorders  and  Therapies.
ublished  by Elsevier  Ltd. This  is an open  access  article  under  the  CC BY  license
(http://creativecommons.org/licenses/by/4.0/).
Organelle facts
• Mitochondria produce vital energy in the form of ATP via
oxidative phosphorylation.
• Mitochondria have their own genome, called mitochondrial
DNA.
• Mitochondria are responsible for most of the reactive oxygen
species via oxidative phosphorylation.
• Mutations in nuclear encoded genes of mitochondrial©  2015  The  Authors.  P
Key facts
• Reactive oxygen species are produced in various cell com-
partments.
• Previously thought of as harmful agents only, they are now
considered as important signaling molecules with potential
therapeutic effect.Abbreviations: I, complex I; II, complex II; III, complex III; IV, complex IV; -
GDH, -ketoglutarate dehydrogenase; AO, alternative oxidase; cyt, cytochrome;
HODH, dihydroorotate dehydrogenase; ETF, electron transfer ﬂavoprotein; GLRX,
lutaredoxin; GPx, glutathione peroxidase; GSH GSSG, glutathione; GSR, glu-
athione reductase; mGPDH, mitochondrial glycerophosphate dehydrogenase;
AO, monoamine oxidase; NADH DH, external NADH dehydrogenase; NOS, nitric
xide synthase; OXPHOS, oxidative phophorylation; PDH, pyruvate dehydroge-
ase; PRXIII, peroxiredoxin III; ROS, reactive oxygen species; TXN2, thioredoxin 2;
XNRD2, thioredoxin reductase.
 This article is part of a Directed Issue entitled: Energy Metabolism Disorders and
herapies.
∗ Corresponding author at: Institute of Human Genetics, Technische Universität
ünchen, Munich, Germany. Tel.: +49 8931872890.
E-mail address: prokisch@helmholtz-muenchen.de (H. Prokisch).
proteins potentially result in inherited diseases, with an inci-
dence of 1 in 10,000, most of them causing neuropathies or
myopathies.
• Mitochondrial diseases of oxidative phosphorylation can be
connected with increased ROS
ttp://dx.doi.org/10.1016/j.biocel.2015.01.021
357-2725/© 2015 The Authors. Published by Elsevier Ltd. This is an open access article u• Mitochondria have their own ROS defense system.
1. Introduction
The discussion about reactive oxygen species (ROS) started
around the year 1956 (Harman, 1956) with the ﬁnding that 2% of
the oxygen which is used up by the respiratory chain in mitochon-
dria can be released and transformed into a superoxide radical
anion O2•− by consuming a single electron coming from the respira-
tory chain. Traditionally, most of the ROS production is believed to
originate from the electron transport chain in mitochondria, espe-
cially from complexes I and III. Later on, many other proteins were
nder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Fig. 1. Sites of ROS production. Many different sites of ROS production exist within a cell. Most of them are located in the mitochondrial environment such as the complexes
of  the respiratory chain: complex I (I), complex II (II), complex III (III), or mitochondrial glycerophosphate dehydrogenase (mGPDH) next to -ketoglutharate dehydrogenases

























tihydroorotate dehydrogenase (DHODH), external NADH dehydrogenase (NADH D
xide  synthase (NOS). Other proteins or organelles can also contribute to ROS produ
rganelles in violet. (For interpretation of the references to color in ﬁgure legend, th
escribed as potential ROS producers, but the exact contribution
rom different sites is not yet fully understood. Many ROS pro-
ucers arise with disruption of cell homeostasis, but, in contrast,
everal proteins produce ROS to restore this homeostasis. Here, we
ummarize sites of reactive oxygen species production and mito-
hondrial defense mechanisms and focus on described roles of ROS
n cell signalization as a beneﬁcial, yet often overlooked effect of
OS in cell metabolism.
. Organelle function: mitochondrial sites of ROS
roduction
Mitochondria play a key role in aerobic cellular metabolism. The
ncomplete oxidation of oxygen to water results in superoxide pro-
uction, virtually ROS. Even though it is still unclear if ROS are only
armful or beneﬁcial, many ROS producing sites were described
Fig. 1). However, an exact contribution of each enzyme is not yet
nown. Complexes of the respiratory chain in mitochondria are
onsidered as main producers, especially complex I in several sites
f the enzyme (Koopman et al., 2010), complex III in subunits inter-
cting with coenzyme Q (Raha et al., 2000; Turrens et al., 1985) and
omplex II under low substrate conditions (Quinlan et al., 2012) as
ell.
Within mitochondria, minor ROS producers can also be found.
irst of all, one protein, which is able to transfer electrons
o the coenzyme Q pool as well as to contribute to the ROSotein p66Shc, cytochrome (cyt) b5 reductase, monoamine oxidase (MAO) and nitric
Respiratory chain complexes are displayed in blue, other ROS contributors in green,
der is referred to the web version of the article.)
formation, is the mitochondrial glycerolphosphate dehydroge-
nase (Drahota et al., 2002). It is located in the inner membrane
facing the intermembrane space. Another signiﬁcant contribu-
tion to ROS production occurs during fatty acid oxidation due to
electron transfer ﬂavoprotein (ETF) that accepts electrons from
different dehydrogenases and transfers them through its mem-
brane partner ETF ubiquinone oxidoreductase to the coenzyme Q
pool in the inner membrane (Ruzicka and Beinert, 1977). Next,
there is a multisubunit pyruvate dehydrogenase complex (Starkov
et al., 2004) and a structurally similar membrane bound enzyme
complex of -ketoglutarate dehydrogenase (-KGDH) which has
been proposed as a source of superoxide and hydrogen perox-
ide under low availability of NAD+, the natural electron acceptor
of -KGDH (Starkov et al., 2004). Many of the aforementioned
proteins contain ﬂavin in their active site, which is directly inter-
acting with electrons and plays a possible role in the electron
leakage.
Aconitase, an enzyme in the mitochondrial matrix, is able to
transform hydrogen peroxide into hydroxyl radicals during a Fen-
ton reaction with its iron–sulphur cluster. Aconitase, though, is
easily inhibited by the presence of superoxide (Vasquez-Vivar et al.,
2000). The function of many proteins is changed upon oxidative
stress in cells. Redox disbalance and subsequent oxidation of, for
example, protein p66Shc, which plays an important role in the reg-
ulation of apoptosis, translocates it into the intermembrane space
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There are several other proteins contributing to mitochon-
rial ROS production either as a superoxide or as a hydrogen
eroxide, most of them non-mammalian: external NADH dehy-
rogenase (Fang and Beattie, 2003b) or alternative oxidase (Fang
nd Beattie, 2003a), proline dehydrogenase (White et al., 2007),
ytochrome b5 reductase (Whatley et al., 1998), monoamine oxi-
ase (Koopman et al., 2010) and dihydroorotate dehydrogenase
Forman and Kennedy, 1976) as well as potentially complex IV
Koopman et al., 2010).
Next to the mitochondrial ROS production, numerous con-
ributing proteins were identiﬁed in the cytoplasm as well. Most
mportant is the family of NADPH oxidases, proteins crucial for
ost defense and killing of microorganisms during phagocytosis
ue to increased ROS production (Hampton et al., 1998). Special
onditions lead to increased ROS production in other organells too:
pon stress, such as the unfolded protein response in the endoplas-
atic reticulum and as part of the long-chain fatty acid oxidation
n peroxisomes (Holmstrom and Finkel, 2014). In the cytoplasm
r within organelles we ﬁnd producers like lipoxygenase, xan-
hine oxidase, cyclooxygenase, cytochrome P450 monoxygenase as
ell as d-amino acid oxidase (Holmstrom and Finkel, 2014). Nitric
xide synthase is a protein responsible for the formation of reac-
ive nitrogen species (Koopman et al., 2010) in the cell cytoplasm.
n overview of proteins so far reported as possible ROS producers
ithin or outside mitochondria is displayed in Fig. 1.
. Cell physiology: ROS scavenging and signalization
Thiol groups within redox-sensitive proteins are most impor-
ant not only for ROS scavenging but also for ROS signaling. Cysteine
esidues, especially with low pKa and a thiolate anion ( S−) at
 physiological pH, are the most prominent responders to redox
hanges, but methionines, tryptophans and tyrosines are prone
s well. Besides, iron–sulphur clusters containing proteins provide
his sulphur from their cysteine residues (e.g. aconitase). An attack
f the peroxide bond leads to the formation of reversible sulphenic
cid ( SOH), which is reactive and can easily be transformed into a
isulﬁde bridge (Fig. 2A). These changes in thiol groups are reverted
y glutathione or thioredoxin systems (Fig. 2B) with the help of the
eroxiredoxin family of enzymes. However, upon ongoing expo-
ure to hydrogen peroxide in the microenvironment, sulphenic
roups can be further oxidized into irreversible sulphinic ( SO2H)
r sulphonic ( SO3H) acids (Koopman et al., 2010).
The ROS scavenging mechanism occurs mainly in mitochon-
ria, but analogous proteins exist in the cytosol. Speciﬁcally in
eroxisomes, organelles producing ROS for their functioning, we
nd catalase, an enzyme capable of decomposing hydrogen per-
xide to water and oxygen, whereas mitochondria have very low
evels of this enzyme. The same removal of hydrogen peroxide is
lso used in mitochondria by peroxiredoxin and glutathione per-
xidase (Fig. 2B), which are oxidized in return. Proteins of the
eroxiredoxin family form dimers upon oxidation, which are oxi-
ized by thioredoxins. Oxidized thioredoxin is then reduced by
hioredoxin reductase in the presence of NADPH. In the other part
f the pathway, oxidized glutathione peroxidase is reduced by
 molecule of glutathione which forms dimers that are restored
y the glutathione reductase. Glutathione is part of the cellular
onenzymatic antioxidant system also including vitamines C and
, carotenoids and ﬂavonoids (Koopman et al., 2010). Reduction of
lutathione peroxidase can also be performed by glutaredoxin, a
olecule providing a possible crosstalk with the thioredoxin path-
ay, speciﬁcally with peroxiredoxin and thioredoxin (Hanschmann
t al., 2010). On the other hand, thioredoxin reductase can directly
ffect peroxiredoxin as well as glutaredoxin and glutathione is able
o reduce thioredoxin directly (Casagrande et al., 2002).f Biochemistry & Cell Biology 63 (2015) 16–20
Due to indirect inhibition of proteins by oxidation of their
thiol group, some of the signaling pathways become unblocked
and therefore active. This is speciﬁcally true for the inactivation
of protein phosphatases by H2O2, thereby increasing the level of
protein phosphorylation (Meng et al., 2002). In contrast, redox
dependent inactivation of protein tyrosine phosphatases may  be
speciﬁc and reversible (Denu and Tanner, 1998). ROS can also
directly affect kinase signaling, for example a receptor tyrosine
kinase (Truong and Carroll, 2013). A second example for the direct
role of ROS in signal transduction was  observed with increased
tyrosine phosporylation occurring after growth factor stimulation
preceded by a burst of ROS generation (Bae et al., 1997; Sundaresan
et al., 1995). As previously mentioned, ROS attack DNA, but their
signalization affects transcription factors, e.g. bacterial OxyR, as
well. This redox sensitive protein regulates the antioxidant stress
response. Oxidation of cytosine residues in OxyR creates an intra-
molecular disulphide bond locking the transcription factor in its
active conﬁguration (Lee et al., 2004; Xanthoudakis and Curran,
1992). Many other pathways and proteins such as actin polymer-
ization, activity of the calcium/calmodulin-dependent kinase, DNA
binding of transcription factors activator protein 1 or forkhead box
protein O, pathways of Kelch-like ECHS-associated protein 1 and
nuclear factor erythroid 2-related factor 2, essential autophagy
protein ATG4 are all connected with ROS production (Holmstrom
and Finkel, 2014). Additionally, various roles were described in
circadian rhythms, innate immunity, metabolic regulations gut
homeostasis, stem cell biology, the pathogenesis of cancer and why
and how we  are aging (Holmstrom and Finkel, 2014). In many of
these mechanisms, mitophagy caused by increased ROS production
serves as a quality control system. Based on several observations, a
principle of redox signaling reveals:
Mutation in gene/Speciﬁc conditions → ↑ ROS → ↑ ROS signal-
ing → higher compensation → (PARTIAL) recovery of normal
status
4. Organelle pathology: impairment of ROS scavenging
system
A number of mutations has been described in genes coding for
respiratory chain complexes, some of them increasing ROS pro-
duction, some of them having no effect. To date, no signiﬁcant
positive effects of antioxidant treatments were observed within
properly performed clinical trials (Pfeffer et al., 2013). On  one
hand decreasing ROS amount in patients had no effect on disease
improvement. On the other hand no increased ROS production
was observed in the mutator mouse model, which is accumulat-
ing mutations in mitochondrial DNA over time (Bratic and Larsson,
2013), nor in mouse model with mutations in NDUFS4 subunit of
complex I (Chouchani et al., 2014). The subunits of the respiratory
chain complexes are impaired by the mutations, yet in these cases
ROS are not part of the pathomechanism. In case of natural ROS
increase, reactive radicals are removed as previously described by
compensatory mechanisms. Nevertheless, several pathologies con-
cerning the scavenging mechanism have been revealed in the past
few years. Recently, Familial glucocorticoid deﬁciency caused by
mutations in the mitochondrial antioxidant thioredoxin reductase
(TXNRD2) has been described (Prasad et al., 2014). Several living
patients were reported in this study. However, in vitro experi-
ments demonstrated that the glutathione system is unable to fully
compensate for the TXNRD2 deﬁciency leading to increased mito-
chondrial superoxide production. Moreover, a mouse knock-out
model showed to be embryonic lethal (Conrad et al., 2004). This is
also the case for a thioredoxin 2 mouse model, where only heterozy-
gous mice are surviving (Nonn et al., 2003). A frameshift mutation
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Fig. 2. Principle of ROS signalization and ROS scavenging mechanism. (A) Redox signalization causes reversible or irreversible modiﬁcation in redox sensitive proteins in
thiol  molecules of cysteine residues. (B) ROS are produced within oxidative phophorylation (OXPHOS) or by other proteins. Reversible redox modiﬁcations are restored due


































pxidation of PRXIII is reduced by thioredoxin 2 (TXN2) with help of thioredoxin re
2O2 and it is subsequently sensed by glutathione (GSH) molecule, which forms d
olecule of glutaredoxin (GLRX).
n human glutaredoxin 2 causing hearing loss was  also reported,
et unfortunately, impaired ROS production was not investigated
Imtiaz et al., 2014). A state characterized by low level of catalase
n the cell environment is called acatalasemia. This is not directly
ausing a disease, but it can contribute to increased risk of develop-
ng other disorders. Understanding the whole mechanism of ROS
cavenging can help to clarify speciﬁc problems and potential ther-
pies in such condition. Concerning all so far reported mutations,
e can conclude that this system is quite robust and even with
ome missing pieces, it is able to compensate or just skip lacking
art via a functioning crosstalk.
. Future outlook
Although redox signalization seems to be less speciﬁc than
ther types of signalization, mechanisms like controlled produc-
ion, cellular localization, time and exposure of cysteine residues
lay an important role. Also, rapid and reversible changes of protein
unction create this extraordinary signalization. Special attention
hould be applied to the speciﬁc level of ROS occurring in the cell
nvironment, making it one of its greatest aspects. Principles can
e similar in many cases, revealing potential selective therapeutic
irections as well. Therefore, it is essential to identify deﬁnite tar-
ets and their function. It can be expected that genome sequencing
f patients will discover more mutations in the defense system.
his will contribute to our understanding of the system. Particular
otential lies in H2O2 which exists naturally in 10 nm intracellular
oncentration and, as it is not charged, is not as reactive as other
adicals and can pass through membranes.
Many diverse details remain to be elucidated and many ques-
ions to be answered, but we already have several hints. ROS
ncrease during both inhibited and reduced amount of substrates,
ypoxia and hyperoxia or endogenous and exogenous stress.
ence, diverse mechanisms must exist to differentiate contrasting
roblems and come to different solutions. Moreover, the origin ofse 2 (TXNRD2). In the glutathione pathway, glutathione peroxidase (GPx) reduces
 (GSSG). The GSH dimers are reduced by the glutathione reductase (GSR) or by a
ROS was  not properly investigated. Do we need ROS because they
protected the original prokaryotic cell to survive in a dangerous
environment (as current NAPDH oxidases) or did they develop later
on purpose? How do we  inﬂuence the level of ROS production? How
can we  gain anything out of that? For this and many other reasons,
a great ﬁeld of redox biology is opened for further research.
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